Pyridazine - CAS 289-80-5
Catalog: |
BB020033 |
Product Name: |
Pyridazine |
CAS: |
289-80-5 |
Synonyms: |
pyridazine |
IUPAC Name: | pyridazine |
Description: | Pyridazine (CAS# 289-80-5) is a useful research chemical compound. |
Molecular Weight: | 80.09 |
Molecular Formula: | C4H4N2 |
Canonical SMILES: | C1=CC=NN=C1 |
InChI: | InChI=1S/C4H4N2/c1-2-4-6-5-3-1/h1-4H |
InChI Key: | PBMFSQRYOILNGV-UHFFFAOYSA-N |
Boiling Point: | 208 °C |
Melting Point: | -8 °C |
Purity: | 95 % |
Density: | 1.103 g/cm3 |
Appearance: | Colorless to brown liquid |
Storage: | Refrigerator |
MDL: | MFCD00006463 |
LogP: | 0.47660 |
GHS Hazard Statement: | H302 (20%): Harmful if swallowed [Warning Acute toxicity, oral]; H315 (100%): Causes skin irritation [Warning Skin corrosion/irritation]; H319 (100%): Causes serious eye irritation [Warning Serious eye damage/eye irritation]; H335 (100%): May cause respiratory irritation [Warning Specific target organ toxicity, single exposure; Respiratory tract irritation] |
Precautionary Statement: | P261, P264, P264+P265, P270, P271, P280, P301+P317, P302+P352, P304+P340, P305+P351+P338, P319, P321, P330, P332+P317, P337+P317, P362+P364, P403+P233, P405, and P501 |
Signal Word: | Warning |
Publication Number | Title | Priority Date |
WO-2015197860-A2 | Novel thapsigargin analogues and methods of preparing them | 20140627 |
US-2015361100-A1 | Indolizine derivatives as phoshoinositide 3-kinases inhibitors | 20140617 |
WO-2015193263-A1 | Indolizine derivatives as phoshoinositide 3-kinases inhibitors | 20140617 |
WO-2015193740-A2 | Therapeutic combinations of a btk inhibitor, a pi3k inhibitor and/or a jak-2 inhibitor | 20140617 |
US-2015361087-A1 | Antiviral compounds | 20140612 |
PMID | Publication Date | Title | Journal |
24224729 | 20140313 | Imidazopyridazine hepatitis C virus polymerase inhibitors. Structure-activity relationship studies and the discovery of a novel, traceless prodrug mechanism | Journal of medicinal chemistry |
23415090 | 20130401 | Synthesis and biological evaluation of pyridazine derivatives as novel HIV-1 NNRTIs | Bioorganic & medicinal chemistry |
23079522 | 20121201 | Design, synthesis and SAR analysis of novel potent and selective small molecule antagonists of NPBWR1 (GPR7) | Bioorganic & medicinal chemistry letters |
23124446 | 20121101 | Cadmium(II) chloride, bromide and iodide complexes with 4,4'-bipyridazine: when are diazine and halide bridges (in)compatible? | Acta crystallographica. Section C, Crystal structure communications |
22969605 | 20120901 | 1-[4-(4-Chloro-phen-yl)piperazin-1-yl]-3-(6-oxo-3,4-diphenyl-1,6-dihydro-pyridazin-1-yl)propan-1-one | Acta crystallographica. Section E, Structure reports online |
Complexity: | 30.5 |
Compound Is Canonicalized: | Yes |
Covalently-Bonded Unit Count: | 1 |
Defined Atom Stereocenter Count: | 0 |
Defined Bond Stereocenter Count: | 0 |
Exact Mass: | 80.03744813600001 |
Formal Charge: | 0 |
Heavy Atom Count: | 6 |
Hydrogen Bond Acceptor Count: | 2 |
Hydrogen Bond Donor Count: | 0 |
Isotope Atom Count: | 0 |
Monoisotopic Mass: | 80.03744813600001 |
Rotatable Bond Count: | 0 |
Topological Polar Surface Area: | 25.8 |
Undefined Atom Stereocenter Count: | 0 |
Undefined Bond Stereocenter Count: | 0 |
XLogP3: | -0.7 |
Online Inquiry
Customer Support
Customer Centered
Related Functional Groups
Pyridazines
Customers Also Viewed
INDUSTRY LEADERS TRUST OUR PRODUCTS